Clinical Trials Logo

Moderate Traumatic Brain Injury clinical trials

View clinical trials related to Moderate Traumatic Brain Injury.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06222502 Recruiting - Clinical trials for Traumatic Brain Injury

Walking After Traumatic Brain Injury in Older Adults

Start date: January 16, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to test the effect of a planning, reminders, and micro-incentives intervention verses regular health education facts on physical activity participation over 12-weeks, in older adults who have previously suffered a non-penetrating mild or moderate TBI. Participants will provide information and be screened for eligibility via phone screening call (verification of age, confirmation that the participant is not currently on any medication that affects the central nervous system, and verification that the subject can participate in exercise, brief TBI history). Baseline testing will take place at the Center for Cognitive and Brain Health and Northeastern University Biomedical Imaging Center, for the baseline magnetic resonance imaging, in the interdisciplinary science and engineering complex on Northeastern University's campus. In person testing will take place over one session. The study period lasts 12 weeks, during which all participants will 1. Receive a weekly phone call with study staff, 2. Wear a wrist-worn Fit Bit tracker and 3. Record their weekly walking activities.

NCT ID: NCT05108909 Recruiting - Clinical trials for MTBI - Mild Traumatic Brain Injury

Rapid Diagnosis and Prognosis Recognition of Imaging and Biomarkers in Mild to Moderate Traumatic Brain Injury

Start date: September 1, 2021
Phase:
Study type: Observational

The investigators will carry out multi-center and large sample research based on the Chinese population, screen the optimal diagnostic and prognosis recognition biomarkers and analyze the diagnostic critical cutoff values in patients with mild to moderate traumatic brain injury, so as to provide a substantial basis for clinical diagnosis and prognosis recognition.

NCT ID: NCT04900168 Recruiting - Clinical trials for Moderate Traumatic Brain Injury

Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury

IPMMTBI
Start date: June 1, 2021
Phase:
Study type: Observational

Objectives The primary focus for scientific investigation is to conduct a multi-center observational study to determine if intracranial pressure (ICP) monitoring to direct treatment of patients with moderate traumatic brain injury (TBI) improves medical practice and patient outcomes in China. Design and Outcomes This is a prospective observational cohort multi-center study with blinded evaluation of outcome. It is a 2-group design. Neurologic outcome is evaluated by extended Glasgow outcome score(GOSE) at 6 months. Interventions and Duration This is an observational study. The decision of intracranial pressure monitoring is made by the relatives of patient. Management of all patients will be consistent with protocols presently being used in the study hospitals. For patients who received ICP monitoring, the management will also be based specifically on the presence of intracranial hypertension. Each patient will be evaluated at 6 months post injury on neurological outcomes. Sample Size and Population 832 patients with moderate traumatic brain injury will be collected on this study.

NCT ID: NCT04766281 Recruiting - Clinical trials for Moderate Traumatic Brain Injury

MLC901 in Moderate Traumatic Brain Injury

ANDROMEDA
Start date: May 1, 2021
Phase: Phase 4
Study type: Interventional

This study wants to evaluate whether MLC901 will help improve the condition of adult patients with moderate traumatic brain injury.

NCT ID: NCT04124029 Recruiting - Clinical trials for Mild Cognitive Impairment

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Start date: July 1, 2021
Phase:
Study type: Observational

This is a research study that aims to examine whether Veterans with mild Traumatic Brain Injuries are at risk for dementia by studying their memory, brain wave activity, brain structure and proteins that can be elevated after brain injury and in dementia.